Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma ; volume:24 ; number:1 ; day:28 ; month:6 ; year:2024 ; pages:1-8 ; date:12.2024
BMC cancer ; 24, Heft 1 (28.6.2024), 1-8, 12.2024
- Creator
-
Zhang, Meng
Li, Zhenjiang
Yin, Yong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12531-z
- URN
-
urn:nbn:de:101:1-2409230945163.749982010762
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Meng
- Li, Zhenjiang
- Yin, Yong
- SpringerLink (Online service)
Other Objects (12)
Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
Targeting CD22 for B-cell hematologic malignancies
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells
CAR-T cell combination therapies in hematologic malignancies
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
Dose rechteckig, Dose Blätter und Dose Punkte, 1936
Dose rechteckig, Dose Blätter und Dose Punkte, 1936
Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
Targeting CD22 for B-cell hematologic malignancies
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells
CAR-T cell combination therapies in hematologic malignancies
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
Dose rechteckig, Dose Blätter und Dose Punkte, 1936
Dose rechteckig, Dose Blätter und Dose Punkte, 1936
Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
Targeting CD22 for B-cell hematologic malignancies
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells
CAR-T cell combination therapies in hematologic malignancies
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
Dose rechteckig, Dose Blätter und Dose Punkte, 1936